Trump signals possible pause on new China tariffs; says TikTok deal may be delayed until broader trade talks see progress.

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

More than 1,000 international students at 128 colleges and universities have had their visas revoked or their legal status ...

The U.S. Food and Drug Administration's mass layoffs included senior negotiators in talks with the pharmaceutical industry ...

The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of ...

The US Senate Judiciary Committee advanced to the full Senate six bills intended to reduce pharmaceutical prices and enhance ...

A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...

President Donald Trump’s executive order targeting fees in the prescription drug supply chain sets up a legal fight with the ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

State officials argue in a lawsuit that the U.S. Constitution expressly gives the authority to impose tariffs to Congress.

Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...

The legal status of cannabis and hemp in the United States remains uncertain, which makes the executive branch’s policy ...